ZTS
HOLD / NEUTRALMeanRevComposite
47.60
Technical
23.50
Fundamental
55.70
Rank
—
Price
74.53
Hurst
0.22
As of
Jul 16, 2026
Daily
Zoetis Inc.
HealthcareDrug Manufacturers - Specialty & GenericZoetis develops and sells medicines, vaccines, diagnostic tools, and genetic testing services for animal health across the United States and globally. The company serves the companion animal market (dogs, cats, horses) and the livestock sector (cattle, swine, poultry, fish, sheep) with products including vaccines, parasiticides, pain relief medications, dermatological treatments, and diagnostic equipment. Its offerings also encompass nutritional supplements and precision health solutions, marketed to veterinarians, farm operators, and pet owners.
Market cap
$30.2B
P/E (trailing)
11.91
P/E (forward)
11.18
PEG ratio
6.79
Dividend yield
290.00%
Beta
0.73
52w range
71.00 – 148.79
Return on equity
+64.91%
Profit margin
+27.68%
Revenue growth
-0.20%
Earnings growth
+1.20%
Price history
1Y: 73.02 (-49.4%) · range 71.36–144.75
Cycle position
22/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 59 · MODERATE · exit proximity 0
Conviction
37/ 100 · maturity 100%
VScore.4016
Buildup.2037
EMA entry setup.2559
Fundamentals.1556
Volume profile
POC
75.61
Price vs POC
-3.4%
Overhead supply
94%
Runway
+2.1%
Value area 73.03–80.24 · 94% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trader-sentiment | 0.111 | Sep 9, 2026 |
| earnings-surprise | 0.004 | Sep 4, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +3.16% | +3.42% | mature |
| 40d | -3.16% | +3.42% | 34/40d |